Shuttle Pharmaceuticals Holdings (SHPH) Depreciation & Amortization (CF) (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Depreciation & Amortization (CF) history runs 6 years deep, the most recent figure standing at $633340.0 for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 62731.35% year-over-year to $633340.0; the TTM figure through Mar 2026 stood at $633369.0 (up 13792.72% YoY), while the FY2025 annual figure was $290107.0, up 5210.4% from the prior year.
• Depreciation & Amortization (CF) was $633340.0 for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from $1008.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $633340.0 in Q1 2026 to a low of -$979.0 in Q2 2025.
• Historically, Depreciation & Amortization (CF) has averaged $40788.9 across 5 years, with a median of $1485.0 in 2022.
• The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) tumbled 201.77% in 2025, then surged 62731.35% in 2026.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $1488.0 in 2022, then jumped by 33.27% to $1983.0 in 2023, then fell by 9.43% to $1796.0 in 2024, then slumped by 43.88% to $1008.0 in 2025, then soared by 62731.35% to $633340.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $633340.0 (Q1 2026), $1008.0 (Q3 2025), and -$979.0 (Q2 2025), per Business Quant data.